Roth Capital Weighs in on Celsius' Q4 Earnings (NASDAQ:CELH)

Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) - Investment analysts at Roth Capital upped their Q4 2025 earnings per share estimates for shares of Celsius in a research report issued on Wednesday, May 7th. Roth Capital analyst S. Mcgowan now forecasts that the company will post earnings of $0.28 per share for the quarter, up from their prior estimate of $0.27. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius' Q3 2026 earnings at $0.31 EPS, Q4 2026 earnings at $0.36 EPS, Q1 2027 earnings at $0.33 EPS and FY2027 earnings at $1.57 EPS.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.02). The firm had revenue of $329.28 million for the quarter, compared to analysts' expectations of $349.09 million. Celsius had a return on equity of 51.89% and a net margin of 10.70%. The firm's revenue was down 7.4% on a year-over-year basis. During the same period last year, the company earned $0.27 earnings per share.

CELH has been the topic of several other reports. Piper Sandler upped their price objective on Celsius from $43.00 to $44.00 and gave the stock an "overweight" rating in a report on Thursday, April 17th. B. Riley reissued a "buy" rating and set a $49.00 target price (up previously from $44.00) on shares of Celsius in a research report on Friday, February 21st. UBS Group boosted their target price on Celsius from $43.00 to $48.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. Stifel Nicolaus cut their target price on Celsius from $45.00 to $37.00 and set a "buy" rating on the stock in a research report on Monday, February 10th. Finally, TD Cowen downgraded Celsius from a "buy" rating to a "hold" rating and cut their target price for the company from $40.00 to $29.00 in a research report on Wednesday, January 22nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $46.88.

Celsius Stock Performance

Shares of CELH traded up $0.59 during mid-day trading on Thursday, hitting $37.91. 3,787,573 shares of the stock were exchanged, compared to its average volume of 9,287,702. The company has a market cap of $9.77 billion, a PE ratio of 86.16, a price-to-earnings-growth ratio of 2.90 and a beta of 1.65. Celsius has a 52-week low of $21.10 and a 52-week high of $98.85. The firm has a 50-day moving average of $34.23 and a two-hundred day moving average of $29.69.

Institutional Investors Weigh In On Celsius

Institutional investors have recently added to or reduced their stakes in the stock. Janney Montgomery Scott LLC boosted its position in Celsius by 85.4% during the fourth quarter. Janney Montgomery Scott LLC now owns 58,178 shares of the company's stock valued at $1,532,000 after purchasing an additional 26,801 shares in the last quarter. Diversified Trust Co bought a new stake in Celsius during the fourth quarter valued at about $869,000. Bennett Selby Investments LP boosted its position in Celsius by 392.6% during the fourth quarter. Bennett Selby Investments LP now owns 51,645 shares of the company's stock valued at $1,360,000 after purchasing an additional 41,161 shares in the last quarter. Annex Advisory Services LLC bought a new stake in Celsius during the fourth quarter valued at about $1,165,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in Celsius by 5.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 22,689 shares of the company's stock valued at $587,000 after buying an additional 1,100 shares during the last quarter. Institutional investors own 60.95% of the company's stock.

Insider Transactions at Celsius

In other news, Director Joyce Russell sold 4,000 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total transaction of $113,880.00. Following the transaction, the director now owns 19,106 shares of the company's stock, valued at approximately $543,947.82. This represents a 17.31% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Paul H. Storey sold 10,188 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $25.77, for a total value of $262,544.76. Following the transaction, the insider now directly owns 45,297 shares in the company, valued at $1,167,303.69. The trade was a 18.36% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.55% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.